Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-06 4:30:50 am | Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH) | GlobeNewsWire |
| 2024-02-13 1:5:0 pm | Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update | GlobeNewswire |
| 2024-01-24 5:0:0 am | Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer | GlobeNewswire |
| 2024-01-23 5:0:0 am | Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism | GlobeNewswire |
| 2023-12-14 5:0:0 am | Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism | GlobeNewswire |
| 2023-12-13 5:0:0 am | Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”) | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information